Feng Li

机构：Baylor College of Medicine, Yunnan University, Drug Discovery Laboratory (Norway), Center for Discovery, Core Laboratories (United States) · ORCID：0000-0002-9680-4614

发表论文 480 篇 · 总被引 15364 次 · h-index 62

代表论文

• Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): a 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trial (2025 · The Lancet Diabetes & Endocrinology · 被引 9)
• Low-dose metformin requires brain Rap1 for its antidiabetic action (2025 · Science Advances · 被引 7)
• Exosome circ-CBLB promotes M1 macrophage polarization in rheumatoid arthritis through the TLR3/TRAF3 signaling axis (2025 · Frontiers in Immunology · 被引 7)
• Isolinderalactone regulates macrophage polarization and efferocytosis by activating the LXRα pathway against ulcerative colitis (2025 · Chinese Medicine · 被引 5)
• Metabolism, Pharmacokinetics, and Tissue Distribution of a Selective FK506-Binding Protein 12 F36V Mutant Degrader in Mice (2025 · ACS Pharmacology & Translational Science · 被引 4)
• Two-Stage Multi-View Graph Spectral Clustering for Single-Cell RNASeq Data (2025 · Current Genomics · 被引 4)